Late Phase and Real-World Evidence Research
OXON Epidemiology is a European-based full service scientific and operational provider of multi-country field, secondary data, and hybrid observational studies for safety, market access/HEOR, drug development and marketing.
Who we are
OXON Epidemiology is a full-service global scientific and operational provider specialising in the generation of Real-World Evidence (RWE) via primary data collection and database observational studies.
We offer a combination of quality science and operational experience to provide life science companies worldwide with real-world evidence for safety, clinical effectiveness, drug use and HEOR endpoints.
Our clients and partners include pharmaceutical and medical devices companies.
With offices in London, Madrid and Kentucky, OXON applies world-class epidemiological and operational experience, and innovative technologies to help clients worldwide obtain high quality RWE for improving patients’ and public health.
We focus on factors that are critical to our clients – reducing the time to market and costs while maintaining quality.
Long Term Strategy
OXON has worked with most of the top 20 biopharma companies and strives to be the ‘Go-To leader’ in the design and implementation of outstanding observational studies.
To such an end we work daily in integrating methodological and statistical thinking and insights to maximise value and provide solutions for our clients for their investments in observational studies.
Our key Strengths
“OXON invests in building and upgrading infrastructure, top talent, and compliant processes to provide more efficient and safer studies to our sponsors”
Discover our key strengths:
Work with us!
Joining the right team can make the difference.
We are looking for talented people who can help us create value for our clients.